Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > 2 milllions for 10 years exclusivity
View:
Post by Stocktree on Feb 22, 2024 10:41am

2 milllions for 10 years exclusivity

That's $200 k a year.

Spectral is really expecting a massive roll out of its "game changer".
Comment by BayStreetWild on Feb 22, 2024 10:48am
Well... You have to add up all the milestone payments. I always knew that it would be at most 5M total for this payment from which they already drew.. so not surprised here. Data would be the game changer for the investing community.. but that doesn't seem to be coming. The trial is back on track so there's that going for Spectral. I can see this hitting 300-400M market cap on speculation ...more  
Comment by Stocktree on Feb 22, 2024 10:55am
If Baxter hadn't paid this 2 million, it would have lost its exclusivity, according to the communique. That would have been a catastrophic assessment of PMX's effectiveness and value. They paid the first sums to have direct access to the data, and once they saw the data, were comfortable enough to offer 2 million for the goods for 10 years. If you still expect this device to hit the ...more  
Comment by palinc2000 on Feb 22, 2024 12:13pm
The milestone payment was used as a carrot ahead of the 90 patient milestone and was not even mentioned in the PR....So Baxter will keep  the  exclusive right to distribute into a MULTI BILLION$ POTENTIAL MARKET for a period of 10 years for a mere 2 million canadian dollrs....No wonder they omitted to disclose that in yesterdays PR  We also learned this morning that at least 15 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities